But abstinence is really a high bar similar to requiring that an antidepressant produce complete remission of depression or that an analgesic totally reduce soreness. Recognizing this limitation, the FDA encourages developers of opioid2 and stimulant3 use dysfunction remedies to discuss with FDA substitute approaches to measure variations in drug https://www.sgvascularctr.com/what-is-clacs/